Categories

Archive for the ‘DISEASES’ Category

Boy Dies from ‘Brain-Eating’ Amoeba Infection Picked Up in Hot Spring

Saturday, September 14th, 2019

This rare infection has a 97% fatality rate

A boy in California died from a rare “brain-eating” amoeba infection after swimming in a hot spring, according to a new report.

In October 2018, the boy swam in a natural freshwater pool in an area known as Hot Ditch, a popular recreational spot in the Eastern Sierra region of California supplied by warm spring water and frequently visited by local residents and tourists alike. Twelve days later, the symptoms set in. After two days of being racked by fever, headaches and vomiting, the boy was brought to an intensive care unit in Southern California, where he experienced respiratory failure.

(more…)

6 in 10 Infectious Diseases Come from Animals. The CDC Is Most Worried About These 8.

Saturday, September 14th, 2019

More than half of the infectious diseases that affect people come from animals. Now, for the first time, the government is releasing a list of the top eight illnesses spread from animals — called zoonotic diseases — in the United States.

(more…)

Can a Detox or Cleanse Process Help Your Liver?

Saturday, August 24th, 2019

You want to do everything you can to take an active role in your health. But if you think you need a liver detox (also known as a liver cleanse or flush), you should know there isn’t much it can do for you.

Your liver is one of the largest organs in your body. It helps remove waste products and processes various nutrients and medicines. Most people think a cleanse will help their liver remove toxins better after too much alcohol or unhealthy foods. Some hope it will help their liver work better on a daily basis. Many believe it’ll help treat liver disease.

Like most detox methods, a liver cleanse has specific steps. You may have to fast or to only drink juices or other liquids for several days. You might need to eat a restricted diet, or take herbal or dietary supplements. Some detoxes also prompt you to buy a variety of other commercial products. Some approaches may combine several of these methods.

Is There Any Proof That Liver Detox Works?

(more…)

Baby loses all his hands & feet after throat infection turns to sepsis

Wednesday, August 14th, 2019

WARNING! GRAPHIC

A mum has shared the horrifying details of her baby losing all four of his limbs after a throat infection turned into deadly sepsis.

Oliver Aisthorpe has made a miraculous recovery after doctors warned mum Abigail Wardle, 23, that her 11-month-old son wasn’t going to pull through.

And even after he beat the infection, Abigail, from Cleethorpes, in the UK, had to endure the horror of Oliver’s leg self-amputating and coming away in her hand as she held him in his hospital bed.

It was a shocking ordeal considering just 48 hours earlier he’d been a happy, giggling little boy.

Oliver Aisthorpe has made a miraculous recovery after a deadly illness robbed him of all four limbs. Picture: Caters News

Oliver Aisthorpe has made a miraculous recovery after a deadly illness robbed him of all four limbs. Picture: Caters News

“Oliver had seemed a bit under the weather. But that night, he got more ill and seemed lifeless,” Abigail said. “When I moved him, it was as though his bones were aching.”

(more…)

A Common Cold Virus Wiped Away Bladder Cancer in One Patient

Saturday, July 13th, 2019

A simple cold virus could wipe out tumors in a form of bladder cancer, a small new study suggests.

Though the idea of using viruses to fight cancer isn’t new, this is the first time a cold virus effectively treated an early-stage form of bladder cancer. In one patient, it eliminated a cancerous tumor, the group reported July 4 in the journal Clinical Cancer Research.

A group of researchers conducted an early-stage clinical trial in which they infected 15 bladder cancer patients with coxsackievirus A21, which is one of the viruses that cause the common cold. Coxsackievirus is not a genetically modified virus; it’s “something that occurs in nature,” said senior author Hardev Pandha, a professor of medical oncology at the University of Surrey in England. [Exercise May Reduce the Risk of These 13 Cancers]

(more…)

Melbourne Australian 54 year old father of two travels to Switzerland to end his life

Friday, February 22nd, 2019

Troy Thornton says he would have preferred to die at home but Victoria’s assisted dying laws − which come into effect only just this year − would not have allowed it.

Troy Thornton with his wife and two children on a family holiday.
Supplied

Retired Melbourne firefighter Troy Thornton is a long way from home.

And he won’t be returning from Europe after deciding to end his life in Switzerland on Friday.

(more…)

Building Practice causing deaths & serious illnesses as reported in Qld Australia

Tuesday, September 18th, 2018

AN IMMEDIATE ban has been issued on a certain building practice after dozens of new cases of the disease silicosis are brought to our attention.

Recent cases of trades people contracting the life-threatening lung disease prompted the Queensland government to announce an immediate ban on dry-cutting artificial stone benchtops.

More than 20 new cases have come forward in the past three weeks alone – including six terminal cases.

Andrew White is a Gold Coast stonemason who went public with his diagnosis, urging other tradies to protect themselves.

(more…)

07 Aug 2018 9:37 AM AEST – Biotoxin-related CIRS illnesses roundtable discussion

Tuesday, August 7th, 2018

The Australian Parliament’s Health, Aged Care and Sport Committee will be holding a roundtable discussion in Canberra on Thursday, 9 August 2018, as part of its Inquiry into Biotoxin-related Illnesses in Australia.

The Committee Chair, Mr Trent Zimmerman MP, said that ‘the Committee will hear a range of perspectives on the possible health effects of dampness and mould, and the prevalence, diagnosis and treatment available for the illness described as Chronic Inflammatory Response Syndrome (CIRS)’.

The Committee will hear from medical professionals and individuals on this topic.

Further information about the inquiry, including the public hearing program, is available at: www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/BiotoxinIllnesses

The hearing will be broadcast live at www.aph.gov.au/live.

PUBLIC HEARING DETAILS:

Canberra

9.30 am to 2.35 pm, Thursday, 9 August 2018

Committee Room 1R1, Australian Parliament House, CANBERRA

RELATED TOPICS & LINKS BELOW

Henry Sapiecha

Australian not-for-profit group wins unprecedented FDA approval for blindness drug

Sunday, July 22nd, 2018

London: An Australian company has won unprecedented US approval for a new drug to treat the second most common preventable cause of blindness in the world.

In the process, Medicines Development for Global Health, based in Melbourne, became the first not-for-profit company in the world to register a medicine with the US Food and Drug Administration.

Mark Sullivan, managing director of Medicines Development for Global Health.

Photo: Supplied

The World Health Organisation has been calling for better treatments for river blindness for more than a decade, but because the medicine would be mostly used by those in poverty-stricken countries, there has been no financial incentive for drug companies to develop new treatments. The current treatment is 20 years old.

River blindness is caused by parasitic worms and spread by black flies. It affects the skin and eyes and is prevalent in sub-Saharan Africa.

In a double-win for Medicines Development for Global Health, it has also won a highly sought after voucher designed to financially reward companies that develop drugs for neglected diseases.

Managing director Mark Sullivan said while FDA approval for the company’s drug, moxidectin, was a “momentous achievement” for any pharma company, it was “a particularly rare and exciting event” for those trying to treat neglected diseases.

The FDA gave its approval for the treatment, which is swallowed as a tablet, in June after the application was submitted in October 2017.

Mr Sullivan established the Melbourne-based not-for-profit company in 2005 with the sole purpose of filling the gap left by the big pharmaceutical companies by developing medicines that were based on need for treatment rather than the patients’ ability to afford them.

Medicines Development for Global Health has been working for five years on the development of the drug and is now planning to develop moxidectin as a new treatment for scabies, a common problem in Indigenous communities.

Priority review voucher

The company has also won a priority review voucher under a scheme set up in 2007 to create a financial incentive to reward drug makers willing to spend the time and money developing treatments for the some of the world’s most neglected diseases. The scheme creates a market for making new drugs that the private market was not filling itself.

Under the scheme, a company that wins a voucher gets a fast track through the FDA for consideration of its  next new drug,  even if it’s a treatment that would have a commercial return. This gives it a head-start over its rivals.

Crucially, a company can also on-sell the voucher to a bigger company willing to pay anywhere between $US100 million and $300 million for the right to almost halve the approval time.

Because Medicines Development for Global Health is a not-for-profit, its proceeds from drug sales and the voucher will be reinvested in the company to develop new drugs & medications for other neglected diseases.

“Our plan is to sell the voucher and use the funds to support further development of moxidectin for other neglected diseases but also to expand our portfolio into other medicines and vaccines,” Mr Sullivan said.

Professor David Ridely from Duke University authored the scheme and said Medicines Development for Global Health was a textbook example of how he envisaged the program would work.

“I’m delighted that the voucher program is playing a role in treating patients with river blindness, and one day eliminating the disease,” he said.

Mr Sullivan said the development of moxidectin could not have been possible without a $US13 million co-investment from the Global Health Investment Fund, which is the social impact investment fund initially put together by the Bill and Melinda Gates Foundation.

”We believe moxidectin may play a pivotal role in eventually eradicating river blindness, and look forward to working with MDGH and others in making this happen,” Curt LaBelle, managing partner at the investment fund, said.

Color-enhanced Scanning Electron Micrograph (SEM) of Onchocerca volvulus, image of a female worm with microfilaria. O. volvulus is a nematode that causes onchocerciasis, or “river blindness,” mostly in Africa. Long-term corneal inflammation, or keratitis, leads to thickening of the corneal stroma which ultimately leads to blindness.

The Food and Drug Administration (FDA) has approved moxidectin for the treatment of onchocerciasis (river blindness) due to Onchocerca volvulus in patients ≥12 years of age.

Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite’s glutamate-gated chloride ion channels. It is active against O. volvulus microfilariae but it does not kill adult O. volvulus parasites. The tropical disease spreads from person to person via black flies that breed near rivers in South and Central America, sub-Saharan Africa and Yemen

RELATED LINKS
 1 in 2 men and 1 in 3 women will develop cancer in their lifetimes. This saddening reality is made worse when it is acknowledged that modern methods of ‘treating’ the disease are often ineffective and only make the symptoms of the disease far worse. In fact, according to one Berkeley doctor, Dr. Hardin B. Jones, chemotherapy doesn’t work 97% of the time.

In the eye-opening video above, Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, discusses how ‘leading edge’ cancer treatment is a sham.

Studied life expectancy of patients for over 25 years

He has personally studied the life expectancy of patients for more than 25 years and has come to the conclusion that chemotherapy does more harm than good. The bone-chilling realization prompted Dr. Jones to speak out against the billion-dollar cancer industry.

“People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy,” said Dr. Jones of his study, which was published in the New York Academy of Science.

“People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.” 

According to the physician, the only reason doctors prescribe chemotherapy is because they make money from it. Such an accusation doesn’t seem unreasonable, as cancer

Patients rejecting conventional therapy live 4x longer

“Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. So this is something that you will not hear in the mass media, which will continue  the myth…”

Despite the fact that the United States spends more on healthcare than any other high-income nation in the world, diseases of affluence continue to increase in prevalence, resulting in a shorter life expectancy.

Perhaps this is because mainstream media and the allopathic healthcare system don’t teach about the importance of preventative medicine. Eating a healthy diet, engaging in exercise, thinking positive thoughts, reducing stress, and enjoying the company of others – or habits that bring joy – are all proven to improve longevity and happiness.

Natural alternatives

In addition, potent all natural medicines, such as cannabis oil, are also strictly regulated and illegal in many areas – despite the fact that CBD-rich oil from the marijuana plant is listed as a remedy on the U.S.’ National Cancer Institute’s website.   www.druglinks.info

As it is, there is no money in a healthy population, which is why fast food joints and pharmaceutical industries thrive in America. Hopefully, Dr. Jones’ efforts will inspire people to seek out alternative options if they or someone they know develops the debilitating disease.

RELATED LINKS BELOW

www.druglinks.info

www.sunblestproducts.com

www.pythonjungle.com

www.ozrural.com.au

Henry Sapiecha